4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001415889-24-009214
CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $66.93 ($1,003,978)
- CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-03-25 | Option exercise 10b5-1 | +15,000 | $1.79 | $26,850 | 492,847 | D |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-03-25 | Sale 10b5-1 | −13,450 | $66.87 | $899,361 | 479,397 | D |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-03-25 | Sale 10b5-1 | −1,550 | $67.50 | $104,617 | 477,847 | D |
| Derivatives | |||||||
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-03-25 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 15,225 | D | ||
| Open-market sales · 15,000 sh · avg $66.93 · $1,003,978 | |||||||
Loading xslF345X05/form4-03272024_080342.xml…